Michael A. Golafshar

Mayo Clinic in Arizona

Papers

1

Total Citations

26

H-Index

1

About

Michael A. Golafshar is a clinical researcher whose work centers on advancing radiation oncology, particularly through proton therapy for challenging cancers. His most notable contribution is the pioneering study "Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience," which has garnered 26 citations and established a foundation for using IMPT in liver cancer treatment. This research demonstrated the safety and efficacy of precisely targeted proton beams for hepatocellular carcinoma, offering a promising alternative to conventional radiation that minimizes damage to healthy liver tissue. Golafshar's work addresses a critical need in oncology—improving outcomes for patients with liver tumors, where organ preservation is paramount. His findings have influenced clinical protocols and sparked further investigation into proton therapy's role in abdominal malignancies. By combining rigorous retrospective analysis with a focus on curative intent, Golafshar has contributed meaningful evidence to the growing field of particle therapy, positioning himself as a key voice in the evolution of precision radiation treatments for complex solid tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
26 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Mayo Clinic in Arizona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago